Abstract
At Samsung Medical Center, we found that 8.9% (189 of 2,119 patients) had HER2 aberrations including amplification, mutations, and fusion by clinical NGS.
Cite
CITATION STYLE
APA
Jung, J., Kim, S. T., Ko, J., Hong, J. Y., Park, J. O., Ha, S. Y., & Lee, J. (2023). Clinical Implication of HER2 Aberration in Patients With Metastatic Cancer Using Next-Generation Sequencing: A Pan-Tumor Analysis. JCO Precision Oncology, (7). https://doi.org/10.1200/po.22.00537
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free